Shockwave Medical is developing the Lithoplasty family of balloon dilatation catheters that incorporate tiny lithotripsy electrodes designed to increase the compliance of rigid vascular and valvular lesions prior to low-pressure dilation, thereby limiting injury to healthy tissue and overcoming significant limitations of current revascularization technologies. The technology is built on traditional balloon catheter platforms rendering it inherently familiar and easy to use for cardiologists, interventional radiologists and vascular surgeons alike. In peripheral vessels, Lithoplasty could enable more effective angioplasty, less frequent bailout stent usage and enhanced lesion preparation prior to the use of drug eluting balloons (DEB) or bio-absorbable vascular scaffolds (BVS). In coronary vessels it could facilitate stent delivery and enhance vessel preparation prior to stent or BVS placement. Finally, in aortic valves the technology could vastly improve native tissue preparation prior to trans-catheter aortic valve replacement (TAVR) and valvuloplasty for those patients not suitable for TAVR.
Show more
Fremont, US
Size (employees)
96 (est)+3%
Shockwave Medical was founded in 2009 and is headquartered in Fremont, US
Report incorrect company information

Key People/Management at Shockwave Medical

Daniel Hawkins

Daniel Hawkins

Founder & CEO

Shockwave Medical Office Locations

Shockwave Medical has offices in Philadelphia and Fremont
Fremont, US (HQ)
Warm Springs Blvd
Show all (2)
Report incorrect company information

Shockwave Medical Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$132.5 m

Latest funding size

$35 m

Time since last funding

6 months ago


Shockwave Medical's latest funding round in October 2017 was reported to be $35 m. In total, Shockwave Medical has raised $132.5 m
Report incorrect company information